Skip to content

Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)

Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04221867
Acronym
ESOGRAFT
Enrollment
20
Registered
2020-01-09
Start date
2021-08-15
Completion date
2023-03-01
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Stricture, Fat Graft

Keywords

Esophageal Stricture, Fat Graft, Dilation

Brief summary

In this study the investigators investigate the feasibility and therapeutic potential of free autologous fat grafting combined to dilation therapy in the treatment of benign esophageal strictures.

Detailed description

In this study the investigators wish to proof the concept of free fat graft transfer into esophageal stricture via flexible video gastroscope.The investigators will recruit twenty patients suffering from (endoscopy proven) benign stricture of the esophagus. The Eckardt score is recorded upon recruitment and one day before operation. The operation is performed at the gastroenterology outpatient clinic in Turku University Hospital by a gastrointestinal surgeon. The patient is sedated with alfentanil and midazolam. First, abdominal liposuction (roughly 20 ml) is performed under local infiltration anesthesia. The fat graft is processed into nano-fat using Tulip GEMS Single-Use NanoTransfer Set. Esophagoscopy with gastroscope is performed and stricture is visually graded (location, length, lumen) and photographed. Then esophageal stricture is biopsied with biopsy forceps and dilated with through-the-scope CRE(controlled radial expansion) balloon dilator. Prepared fat graft is injected beneath the mucosal layer at the stricture site (volume of 0,1-0,5 ml) at three locations. Patients are either discharged after two hours follow up or admitted to the inpatient ward, depending on the pre- and postoperative condition. Patients are contacted by phone 1 week after the operation. Post-operative symptoms are recorded and patients are requested to contact the researcher if needed. Patient records are screened for pre- and postoperative symptoms, medication, long term illnesses and possible postoperative contacts to hospital. Follow-up esophagoscopy is performed and biopsies taken three and 12 months after the first operation. The stricture site is visually graded and photographed. The Eckardt score is recorded. If the patient has problems with eating (Eckardt score dysphagia points more than 1) the stricture is re-dilated and fat grafting repeated. If a patient would have recurrence in dysphagia before three months the patient is treated according to normal routine and dilation is repeated earlier. The follow-up time is 12 months counting from the last fat grafting.

Interventions

PROCEDUREStricture dilation with CRE balloon

Esophageal stricture is treated by dilation therapy.

Autologous fat graft is gathered and injected to stricture

Sponsors

Hannes Kortekangas
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Esophageal stricture that has re-occurred at least once

Exclusion criteria

* Malignant etiology of esophageal stricture

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Treatment-Emergent Adverse Events at 3 months3 monthsTypes, severity and probability of procedure related adverse events
Incidence of Treatment-Emergent Adverse Events at 12 months12 monthsTypes, severity and probability of procedure related adverse events

Secondary

MeasureTime frameDescription
Change from Baseline Stricture Lumen diameter at 3 months3 monthsStricture photographed and lumen diameter measurement. Unit: closed biopsy forceps diameter.
Change from Baseline Stricture Lumen diameter at 12 months12 monthsStricture photographed and lumen diameter measurement. Unit: closed biopsy forceps diameter.
Change from Baseline Eckardt score at 3 months3 monthsEckardt score is a validated symptom questionnaire used to measure achalasia symptoms. Esophageal stricture symptoms are similar to achalasia symptoms. Sub scales: Dysphagia, retrosternal pain, regurgitation, weight loss. Each sub scale 0-3 points. 0=none, 1=occasional / less than 5 kg, 2=daily / 5-10kg, 3= each meal /more than 10 kg. Total 0-12 points.
Change from Baseline Stricture length at 12 months12 monthsStricture length measured using shaft of biopsy forceps. Unit: mm.
Change from Baseline Stricture length at 3 months3 monthsStricture length measured using shaft of biopsy forceps. Unit: mm.
Change from Baseline Eckardt-score at 12 months12 monthsEckardt score is a validated symptom questionnaire used to measure achalasia symptoms. Esophageal stricture symptoms are similar to achalasia symptoms. Sub scales: Dysphagia, retrosternal pain, regurgitation, weight loss. Each sub scale 0-3 points. 0=none, 1=occasional / less than 5 kg, 2=daily / 5-10kg, 3= each meal /more than 10 kg. Total 0-12 points.

Contacts

Primary ContactHannes A Kortekangas, Surgeon
hannes.kortekangas@tyks.fi+35823139192

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026